RedHill Biopharma (RDHL) Net Income towards Common Stockholders (2012 - 2023)
RedHill Biopharma (RDHL) recorded Net Income towards Common Stockholders of -$429,000 in the year ended Dec 31, 2025, compared with -$8.27 million a year earlier.
Powered by 
Analysis
RedHill Biopharma (RDHL) Net Income towards Common Stockholders (2012 - 2023) Analysis & Trends
Starting with the year ended Dec 31, 2009, RedHill Biopharma's Net Income towards Common Stockholders history includes 17 years.
- Annual Net Income towards Common Stockholders has ranged from -$97.74 million in the year ended Dec 31, 2021 to $23.92 million in the year ended Dec 31, 2023 over the past five years.
- Per Business Quant data, RDHL's Net Income towards Common Stockholders was -$8.27 million in the year ended Dec 31, 2024, $23.92 million in the year ended Dec 31, 2023, -$71.67 million in the year ended Dec 31, 2022 and -$97.74 million in the year ended Dec 31, 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 7.10 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 5.53 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.61 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -1.34 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.26 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.38 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.50 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | -248.00 Mn |
| 10 | RedHill Biopharma | 7.38 Mn | 7.38 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | 101.24 Mn |
| Mar 31, 2023 | -50.24 Mn |
| Dec 31, 2022 | -3.73 Mn |
| Sep 30, 2022 | -35.70 Mn |
| Jun 30, 2022 | -11.71 Mn |
| Mar 31, 2022 | 20.53 Mn |
| Dec 31, 2021 | -24.37 Mn |
| Sep 30, 2021 | -21.39 Mn |
| Jun 30, 2021 | -29.12 Mn |
| Mar 31, 2021 | -22.86 Mn |
| Dec 31, 2020 | 24.33 Mn |
| Sep 30, 2020 | 18.64 Mn |
| Jun 30, 2020 | 16.05 Mn |
| Mar 31, 2020 | 17.16 Mn |
| Dec 31, 2019 | 11.69 Mn |
| Sep 30, 2019 | 9.84 Mn |
| Jun 30, 2019 | 10.91 Mn |
| Mar 31, 2019 | 9.87 Mn |
| Dec 31, 2018 | 7.68 Mn |
| Sep 30, 2018 | 10.08 Mn |
API Access
RedHill Biopharma Net Income towards Common Stockholders API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=RDHL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income-towards-common-stockholders", "ticker": "RDHL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=RDHL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();